Back
ProQR Therapeutics NV Quote, Financials, Valuation and Earnings
Sponsored
PRQR
Sponsored
America's Final Republican President
Click here to see his 2024 election prediction.
Buy
55
PRQR
ProQR Therapeutics NV
Last Price:
1.95
Seasonality Move:
1.68%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.ProQR Therapeutics NV Price Quote
$1.95
+0.01 (+-0.51%)
(Updated: April 27, 2024 at 6:17 AM ET)
ProQR Therapeutics NV Key Stats
Buy
55
ProQR Therapeutics NV (PRQR)
is a Buy
Day range:
$1.93 - $1.99
52-week range:
$1.11 - $3.29
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
22.31
P/B ratio:
3.45%
Volume:
50.8K
Avg. volume:
166.4K
1-year change:
-12.22%
Market cap:
$157.8M
Revenue:
$7.1M
EPS:
$-0.38
How Much Does ProQR Therapeutics NV Make?
-
How Much Are ProQR Therapeutics NV's Sales Annually?
PRQR Revenues are $7.1M -
How Much Profit Does ProQR Therapeutics NV's Make A Year?
PRQR net income is -$30.4M
Is ProQR Therapeutics NV Growing As A Company?
-
What Is ProQR Therapeutics NV's Growth Rate Quarterly?
Quarterly YoY revenue growth is 3.8% -
What Is ProQR Therapeutics NV's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ProQR Therapeutics NV Stock Price Performance
-
Did ProQR Therapeutics NV Stock Go Up Last Month?
ProQR Therapeutics NV share price went down by -19.17% last month -
Did PRQR's Share Price Rise Over The Last Year?
PRQR share price fell by -12.22% over the past 1 year
What Is ProQR Therapeutics NV 52-Week High & Low?
-
What Is ProQR Therapeutics NV’s 52-Week High Share Price?
ProQR Therapeutics NV has traded as high as $3.29 over the past 52 weeks -
What Is ProQR Therapeutics NV’s 52-Week Low Share Price?
ProQR Therapeutics NV has traded as low as $1.11 over the past 52 weeks
ProQR Therapeutics NV Price To Free Cash Flow
-
Is ProQR Therapeutics NV Stock Overvalued?
ProQR Therapeutics NV is trading at a price to free cash flow ratio of 7.19 -
Is ProQR Therapeutics NV Stock Undervalued?
ProQR Therapeutics NV EV to Free Cash Flow ratio is 1.42 -
What Is ProQR Therapeutics NV’s Price Earnings Growth Ratio?
PRQR PEG ratio is 0.00 -
Is ProQR Therapeutics NV Trading At A Premium To Earnings?
ProQR Therapeutics NV EV to EBIT ratio is 0.00
Is It Risky To Buy ProQR Therapeutics NV?
-
How Much Debt Does ProQR Therapeutics NV Have?
Total long term debt quarterly is $4.7M -
How Much Cash Does ProQR Therapeutics NV Have?
Cash and short term investments quarterly total is $131.5M -
What Is ProQR Therapeutics NV’s Book Value Per Share?
Book value per share is 0.56
Is ProQR Therapeutics NV Cash Flow Positive?
-
What Is PRQR Cash Flow From Operations?
Cash flow from operations (TTM) is $23.3M -
What Is ProQR Therapeutics NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2.5M -
What Is ProQR Therapeutics NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is $4.6M
ProQR Therapeutics NV Return On Invested Capital
-
Is Management Doing A Good Job?
PRQR return on invested capital is -47.86% -
What Is ProQR Therapeutics NV Return On Assets?
ROA measures how assets are converting to revenues and is -18.57% -
What Is PRQR Return On Equity?
ROE is a measure of profitability and is -53.15%
ProQR Therapeutics NV Earnings Date & Stock Price
-
What Is ProQR Therapeutics NV's Stock Price Today?
A single share of PRQR can be purchased today for 1.94 -
What Is ProQR Therapeutics NV’s Stock Symbol?
ProQR Therapeutics NV trades on the nasdaq under the ticker symbol: PRQR -
When Is ProQR Therapeutics NV’s Next Earnings Date?
The next quarterly earnings date for ProQR Therapeutics NV is scheduled on May 16, 2024 -
When Is PRQR's next ex-dividend date?
ProQR Therapeutics NV's next ex-dividend date is April 28, 2024 -
How To Buy ProQR Therapeutics NV Stock?
You can buy ProQR Therapeutics NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ProQR Therapeutics NV Competitors
-
Who Are ProQR Therapeutics NV's Competitors?
Below is a list of companies who compete with ProQR Therapeutics NV or are related in some way:
ProQR Therapeutics NV Dividend Yield
Data Unavailable
ProQR Therapeutics NV Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 33.54% |
Revenue: | 380.37% | -57.33% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 4.10 |
Upside from Last Price: | 111.34% |